Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys
Amarendra Pegu, Ling Xu, Megan Demouth, et al.
Cell Reports (2022) Vol. 38, Iss. 1, pp. 110199-110199
Open Access | Times Cited: 24

Showing 24 citing articles:

Prevention, treatment and cure of HIV infection
Raphael J. Landovitz, Hyman Scott, Steven G. Deeks
Nature Reviews Microbiology (2023) Vol. 21, Iss. 10, pp. 657-670
Closed Access | Times Cited: 79
Biparatopic antibodies: therapeutic applications and prospects
David L. Niquille, Kyle M. Fitzgerald, Nimish Gera
mAbs (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 24
Divide and conquer: broadly neutralizing antibody combinations for improved HIV-1 viral coverage
Kshitij Wagh, Michael S. Seaman
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 164-170
Open Access | Times Cited: 14
Broadly neutralizing antibodies targeting HIV: Progress and challenges
Paneerselvam Nandagopal, Amber Khan, Brian R. Lawson
Clinical Immunology (2023) Vol. 257, pp. 109809-109809
Closed Access | Times Cited: 13
How could HIV-1 drug resistance impact preexposure prophylaxis for HIV prevention?
Urvi M. Parikh, John W. Mellors
Current Opinion in HIV and AIDS (2022) Vol. 17, Iss. 4, pp. 213-221
Open Access | Times Cited: 20
SIV monoclonal antibody administration spanning treatment interruption in macaques delays viral rebound and selects escape variants
Hannah A. D. King, Daniel Brammer, Éric Lewitus, et al.
Proceedings of the National Academy of Sciences (2025) Vol. 122, Iss. 5
Open Access
Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention
Bryan T. Mayer, Allan C. deCamp, Yunda Huang, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 4, pp. e1010003-e1010003
Open Access | Times Cited: 18
Adeno-associated virus-vectored delivery of HIV biologics: the promise of a “single-shot” functional cure for HIV infection
P. Hahn, Maurício A. Martins
Journal of Virus Eradication (2023) Vol. 9, Iss. 1, pp. 100316-100316
Open Access | Times Cited: 8
A Germline-Targeting Chimpanzee SIV Envelope Glycoprotein Elicits a New Class of V2-Apex Directed Cross-Neutralizing Antibodies
Frédéric Bibollet‐Ruche, Ronnie M. Russell, Wenge Ding, et al.
mBio (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Interventions during Early Infection: Opening a Window for an HIV Cure?
Christopher R. Hiner, April L. Mueller, Hang Su, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1588-1588
Open Access | Times Cited: 2
Challenges and Opportunities of Therapies Targeting Early Life Immunity for Pediatric HIV Cure
Stella J. Berendam, Ashley N. Nelson, Bhrugu Yagnik, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 10
Complement contributes to antibody-mediated protection against repeated SHIV challenge
Benjamin S. Goldberg, David A. Spencer, Shilpi Pandey, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 20
Open Access | Times Cited: 6
A multispecific antibody prevents immune escape and confers pan-SARS-CoV-2 neutralization
John Misasi, Ronnie R. Wei, Lingshu Wang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 5
Engineering strategies of Anti-HIV antibody therapeutics in clinical development
Nicole Loren Pihlstrom, Stylianos Bournazos
Current Opinion in HIV and AIDS (2023) Vol. 18, Iss. 4, pp. 184-190
Closed Access | Times Cited: 2
Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses
Sarah Lovelace, Sabrina Helmold Hait, Eun Sung Yang, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105067-105067
Open Access | Times Cited: 4
HIV broadly neutralizing antibody escapability drives the therapeutic efficacy of vectored immunotherapy
Nicolás M. S. Gálvez, Yi Cao, Adam D. Nitido, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
A multispecific antibody against SARS-CoV-2 prevents immune escape in vitro and confers prophylactic protection in vivo
John Misasi, Ronnie R. Wei, Lingshu Wang, et al.
Science Translational Medicine (2024) Vol. 16, Iss. 768
Closed Access
Immune Response to HIV-1 Infection and Vaccine Development
Anna Hargrave, Abu Salim Mustafa, Asma Hanif, et al.
IntechOpen eBooks (2023)
Open Access | Times Cited: 1
Rational Design and Characterization of Trispecific Antibodies Targeting the HIV-1 Receptor and Envelope Glycoprotein
Jinhu Liang, Linlin Zhai, Zuxin Liang, et al.
Vaccines (2023) Vol. 12, Iss. 1, pp. 19-19
Open Access | Times Cited: 1
Emerging Antibodies in Cancer Therapy
Yaping Sun, Jian Xu
Advanced NanoBiomed Research (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 2
Immunosuppression and Immunomodulation

IntechOpen eBooks (2022)
Open Access | Times Cited: 1
Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report
Jennifer Cable, Siddharth Balachandran, Lisa P. Daley‐Bauer, et al.
Annals of the New York Academy of Sciences (2023) Vol. 1521, Iss. 1, pp. 32-45
Closed Access
Germline-targeting chimpanzee SIV Envelopes induce V2-apex broadly neutralizing-like B cell precursors in a rhesus macaque infection model
Rami Musharrafieh, Yana Safonova, Ge Song, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A germline-targeting chimpanzee SIV envelope glycoprotein elicits a new class of V2-apex directed cross-neutralizing antibodies
Frédéric Bibollet‐Ruche, Ronnie M. Russell, Wenge Ding, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access
Page 1

Scroll to top